Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Orphanet Journal of Rare Diseases|September 30, 2015
Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years' treatmentChristoph Kampmann, Amandine Perrin, Michael Beck
Thyroid : Official Journal of the American Thyroid Association|August 8, 2002
Cardiovascular hemodynamics and exercise tolerance in thyroid diseaseGeorge J Kahaly, Christoph Kampmann, Susanne Mohr-Kahaly
Archives of Medical Science : AMS|October 3, 2014
Intra- or extracardiac Fontan operation? A simple strategy when to do whatWlodzimierz Kuroczynski, David Senft, Amelie Elsaesser, et al.
The Journal of Pediatrics|May 3, 2011
Prevalence and characterization of cardiac involvement in Hunter syndromeChristoph Kampmann, Michael Beck, Isabelle Morin, et al.
Clinical Therapeutics|October 22, 2009
Effect of agalsidase alfa replacement therapy on Fabry disease-related hypertrophic cardiomyopathy: a 12- to 36-month, retrospective, blinded echocardiographic pooled analysisChristoph Kampmann, Ales Linhart, Richard B Devereux, et al.
Molecular Genetics and Metabolism|December 31, 2018
Early detection of organ involvement in Fabry disease by biomarker assessment in conjunction with LGE cardiac MRI: results from the SOPHIA studyFrank Weidemann, Meinrad Beer, Martina Kralewski, et al.
Journal of Perinatal Medicine|September 7, 2011
Natriuretic peptide levels in intrauterine growth-restricted fetuses with absent and reversed end-diastolic flow of the umbilical artery in relation to ductus venosus flow velocitiesFranz Bahlmann, Frank Krummenauer, Stephan Spahn, et al.
Journal of Clinical Medicine|June 10, 2023
The Prevalence of and Predisposing Factors for Late Atrial Arrhythmias after Transcatheter Closure of Secundum Atrial Septal Defects in ChildrenTariq Abu-Tair, Claudia Martin, Christiane M Wiethoff, et al.
Herz|November 20, 2002
Fabry disease: focus on cardiac manifestations and molecular mechanismsAndreas Perrot, Karl Josef Osterziel, Michael Beck, et al.
Genetics and Molecular Biology|October 19, 2018
Evaluating enzyme replacement therapies for Anderson-Fabry disease: commentary on a recent reportRoberto Giugliani, Stephanie Westwood, Hartmann Wellhoefer, et al.
Pageof 8